Additional file 5 of TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer
收藏NIAID Data Ecosystem2026-03-11 收录
数据链接：
官方服务：
资源简介：
Additional file 5. Appendix 2. Summary statistics for all tested small RNA features in sequencing data (sorted by letozole/bevacizumab responder P).
附加文件5 附录2. 测序数据中所有经检测的小RNA特征（small RNA features）的汇总统计信息（按来曲唑（letozole）/贝伐珠单抗（bevacizumab）应答者P值排序）
创建时间：
2020-02-18
